Biogen's Alzheimer's drug could cost Medicare billions of dollars a year, report finds
June 10, 2021 at 13:56 PM EDT
Biogen said it is charging $56,000 for an annual course of the new treatment, higher than the $10,000 to $25,000 price some Wall Street analysts were expecting.